Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alpha Tau Medical Ltd (DRTS)
NASDAQ:DRTS
RESEARCH TOOLSreports
Holding DRTS?
Track your performance easily
DRTS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.75 - $3.40
Previous Close$2.32
Volume14.75K
Average Volume (3M)23.18K
Market Cap
$162.22M
Enterprise Value$87.11M
Total Cash (Recent Filing)$81.79M
Total Debt (Recent Filing)$6.67M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Mar 06, 2025EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding69,670,612
10 Day Avg. Volume27,867
30 Day Avg. Volume23,184
Standard Deviation0.14
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.90
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda10.64
Forecast
1Y Price Target
$7.33Price Target Upside215.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Alpha Tau Medical Ltd News
PremiumCompany Announcements
Alpha Tau Medical Advances in Cancer Treatment Technology
PremiumCompany Announcements
Alpha Tau Medical to Showcase at Key Healthcare Conferences
PremiumCompany Announcements
Alpha Tau Medical to Hold Annual Shareholder Meeting
PremiumCompany Announcements
Alpha Tau Joins FDA Program to Advance Cancer Therapy
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.70% Other Institutional Investors
99.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DRTS FAQ
What was Alpha Tau Medical Ltd’s price range in the past 12 months?
Alpha Tau Medical Ltd lowest stock price was $1.75 and its highest was $3.40 in the past 12 months.
What is Alpha Tau Medical Ltd’s market cap?
Currently, no data Available
When is Alpha Tau Medical Ltd’s upcoming earnings report date?
Alpha Tau Medical Ltd’s upcoming earnings report date is Mar 06, 2025 which is in 102 days.
How were Alpha Tau Medical Ltd’s earnings last quarter?
Alpha Tau Medical Ltd released its earnings results on Nov 19, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.02.
Is Alpha Tau Medical Ltd overvalued?
According to Wall Street analysts Alpha Tau Medical Ltd’s price is currently Undervalued.
Does Alpha Tau Medical Ltd pay dividends?
Alpha Tau Medical Ltd does not currently pay dividends.
What is Alpha Tau Medical Ltd’s EPS estimate?
Alpha Tau Medical Ltd’s EPS estimate is -$0.12.
How many shares outstanding does Alpha Tau Medical Ltd have?
Alpha Tau Medical Ltd has 69,924,160 shares outstanding.
What happened to Alpha Tau Medical Ltd’s price movement after its last earnings report?
Alpha Tau Medical Ltd reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alpha Tau Medical Ltd?
Among the largest hedge funds holding Alpha Tau Medical Ltd’s share is Highbridge Capital Management LLC. It holds Alpha Tau Medical Ltd’s shares valued at N/A.
---
Alpha Tau Medical Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.33 (215.95% Upside)
$7.33 (215.95% Upside)
Hedge Fund Trend
Decreased
By 60.0 Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.40%
12-Months-Change
Fundamentals
Return on Equity
-37.22%
Trailing 12-Months
Asset Growth
-15.00%
Trailing 12-Months
Company Description
Alpha Tau Medical Ltd
Alpha Tau is an Israel-based medical device company focusing on the research, development, and potential commercialization of the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid tumors.
---
DRTS Stock 12 Month Forecast
Average Price Target
$7.33
▲(215.95% Upside)
Technical Analysis
Black Diamond Therapeutics
―
ZyVersa Therapeutics
―
Mustang Bio
―
TScan Therapeutics
―
Best Analysts Covering DRTS
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-15.92%
reiterated a buy rating 3 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -15.92% per trade.
---